Rachel D. Slack

910 total citations
23 papers, 718 citations indexed

About

Rachel D. Slack is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rachel D. Slack has authored 23 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rachel D. Slack's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Rachel D. Slack is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Rachel D. Slack collaborates with scholars based in United States, United Kingdom and Denmark. Rachel D. Slack's co-authors include Gary H. Posner, Darryl Jones, S. Squires, K. R. H. Wooldridge, Jill P. Pell, Amy Hauck Newman, Andrew D. Flapan, S. Harding, David E. Newby and Nicholas L. Cruden and has published in prestigious journals such as Journal of Medicinal Chemistry, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Rachel D. Slack

23 papers receiving 683 citations

Peers

Countries citing papers authored by Rachel D. Slack

Since Specialization

Citations

This map shows the geographic impact of Rachel D. Slack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel D. Slack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel D. Slack more than expected).

Fields of papers citing papers by Rachel D. Slack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel D. Slack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel D. Slack. The network helps show where Rachel D. Slack may publish in the future.

Co-authorship network of co-authors of Rachel D. Slack

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel D. Slack. A scholar is included among the top collaborators of Rachel D. Slack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel D. Slack. Rachel D. Slack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter 2019 ·ACS Chemical Neuroscience ·Rachel D. Slack, Ara M. Abramyan, Helen Tang, (unknown), Bruce A. Davis, Alessandro Bonifazi, (unknown), Jeffrey R. Deschamps, (unknown), Hideaki Yano, Satinder K. Singh, Amy Hauck Newman, Lei Shi	8
2	Effects of (R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell 2019 ·ACS Chemical Neuroscience ·Jacqueline D. Keighron, Juliana C. Quarterman, Jianjing Cao, (unknown), Mark A. Coggiano, (unknown), Rachel D. Slack, Claudio Zanettini, Amy Hauck Newman, Gianluigi Tanda	20
3	Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics 2018 ·Neuropharmacology ·Ara M. Abramyan, Rachel D. Slack, (unknown), Bruce A. Davis, Amy Hauck Newman, Satinder K. Singh, Lei Shi	21
4	Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor R-modafinil on co-use of ethanol and nicotine in female P rats. 2018 ·PMC ·(unknown), (unknown), (unknown), Kimberly Nixon, Mark Prendergast, Guangrong Zheng, Peter A. Crooks, Linda P. Dwoskin, Rachel D. Slack, Amy Hauck Newman, Richard L. Bell, Michael T. Bardo	1
5	Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats 2018 ·Psychopharmacology ·(unknown), (unknown), (unknown), Kimberly Nixon, Mark Prendergast, Guangrong Zheng, Peter A. Crooks, Linda P. Dwoskin, Rachel D. Slack, Amy Hauck Newman, Richard L. Bell, Michael T. Bardo	11
6	Distinct effects of (R)‐modafinil and its (R)‐ and (S)‐fluoro‐analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats 2018 ·European Journal of Neuroscience ·Jacqueline D. Keighron, (unknown), (unknown), (unknown), Mark A. Coggiano, Rachel D. Slack, Amy Hauck Newman, Gianluigi Tanda	15
7	Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats 2017 ·Neuropharmacology ·Brendan J. Tunstall, (unknown), Jianjing Cao, Janaina C. M. Vendruscolo, Brooke E. Schmeichel, Rachel D. Slack, Gianluigi Tanda, Alexandra J. Gadiano, Rana Rais, Barbara S. Slusher, George F. Koob, Amy Hauck Newman, Leandro F. Vendruscolo	25
8	R-Modafinil Attenuates Nicotine-Taking and Nicotine-Seeking Behavior in Alcohol-Preferring Rats 2015 ·Neuropsychopharmacology ·Xiaofei Wang, Guo‐Hua Bi, Yi He, Hongju Yang, J Gao, (unknown), Rachel D. Slack, Eliot L. Gardner, Zheng‐Xiong Xi, Amy Hauck Newman	16
9	Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands 2015 ·Bioorganic & Medicinal Chemistry ·Thomas M. Keck, Ashwini K. Banala, Rachel D. Slack, (unknown), Alessandro Bonifazi, (unknown), M. H. Moore, Jeffrey R. Deschamps, Rana Rais, Barbara S. Slusher, Amy Hauck Newman	27
10	Clinical outcomes following radial versus femoral artery access in primary or rescue percutaneous coronary intervention in Scotland: retrospective cohort study of 4534 patients 2012 ·Heart ·Cathy Johnman, Jill P. Pell, Daniel Mackay, Miles Behan, Rachel D. Slack, Keith G. Oldroyd, Colin Berry	39
11	Malaria-Infected Mice Live Until at Least Day 30 after a New Artemisinin-Derived Thioacetal Thiocarbonate Combined with Mefloquine Are Administered Together in a Single, Low, Oral Dose 2012 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Rachel D. Slack, Abhai K. Tripathi, David Sullivan, Gary H. Posner	14
12	Perioperative and long-term outcomes following aortic valve replacement: a population cohort study of 4124 consecutive patients 2011 ·European Journal of Cardio-Thoracic Surgery ·Ross McLean, Andrew Briggs, Rachel D. Slack, Vipin Zamvar, Geoffrey Berg, Hussein El-Shafei, Keith G. Oldroyd, Jill P. Pell	9
13	Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration 2011 ·Behavioural Pharmacology ·Kevin T. Ball, (unknown), (unknown), Rachel D. Slack	22
14	Malaria-Infected Mice Are Completely Cured by One 6 mg/kg Oral Dose of a New Monomeric Trioxane Sulfide Combined with Mefloquine 2011 ·Journal of Medicinal Chemistry ·Rachel D. Slack, Bryan T. Mott, Lauren E. Woodard, Abhai K. Tripathi, David Sullivan, Elizabeth Nenortas, Sonya Tang Girdwood, Theresa A. Shapiro, Gary H. Posner	25
15	Antimalarial peroxides: advances in drug discovery and design 2011 ·MedChemComm ·Rachel D. Slack, (unknown), Gary H. Posner	100
16	Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery 2010 ·Circulation Cardiovascular Interventions ·Nicholas L. Cruden, S. Harding, Andrew D. Flapan, (unknown), Sarah H. Wild, Rachel D. Slack, Jill P. Pell, David E. Newby	101
17	Percutaneous Coronary Intervention in the Elderly 2010 ·Circulation Cardiovascular Interventions ·Cathy Johnman, Keith G. Oldroyd, (unknown), Rachel D. Slack, A C H Pell, Andrew D. Flapan, (unknown), Hany Eteiba, John Irving, Jill P. Pell	41
18	Drug-Eluting Stents Versus Bare-Metal Stents for Off-Label Indications 2008 ·Circulation Cardiovascular Interventions ·David Austin, Keith G. Oldroyd, Alex McConnachie, Rachel D. Slack, Hany Eteiba, Andrew D. Flapan, (unknown), Robin J. Northcote, A C H Pell, Ian R. Starkey, Jill P. Pell	12
19	Synthesis and In Vitro Protozoocidal Evaluation of Novel Diazabicyclic Tropolone Derivatives 2007 ·Archiv der Pharmazie ·(unknown), Rachel D. Slack, Richard C. Remsing, Susan Little, Vanessa Yardley, Guillermo Moyna	7
20	Antiviral Chemotherapy. I. The Activity of Pyridine and Quinoline Derivatives against Neurovaccinia in Mice 1965 ·Journal of Medicinal Chemistry ·Darryl Jones, Rachel D. Slack, S. Squires, K. R. H. Wooldridge	117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact